Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial Carcinoma

15 Jul 2022

Abstract excerpt

BACKGROUND: Long non-coding RNAs (lncRNA) have been implicated in a hand of studies that supported an involvement and co-operation in Uterine Corpus Endometrial Carcinoma (UCEC). Enhancer RNAs (eRNA), a functional subtype of lncRNA, have a key role throughout the genome to guide protein production, thus potentially associated with diseases. METHODS: In this study, we mainly applied the Cancer Genome Atlas (TCGA)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis
Share to RNA modifications and cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35836132
DOI: 10.1186/s12575-022-00172-0

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A comprehensive prognostic and immune analysis of enhancer RNA identifies IGFBP7-AS1 as a novel prognostic biomarker in Uterine Corpus Endometrial CarcinomaPMID 35836132Read ↗

Identification of the Prognostic LncRNA Biomarkers and Comprehensive Analysis of LncRNA-Mediated ceRNA Network for Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

CDKN2B-AS1 Promotes Malignancy as a Novel Prognosis-Related Molecular Marker in the Endometrial Cancer Immune MicroenvironmentSemantic proximity Read ↗

Identification of long noncoding RNA RP11-89K21.1 and RP11-357H14.17 as prognostic signature of endometrial carcinoma via integrated bioinformatics analysisSemantic proximity Read ↗

An Immune-Related Long Noncoding RNA Signature as a Prognostic Biomarker for Human Endometrial CancerSemantic proximity Read ↗

Identifying immune subtypes of uterine corpus endometrial carcinoma and a four-paired-lncRNA signature with immune-related lncRNAs.Semantic proximity Read ↗

Pan-Cancer Gene Analysis of m6A Modification and Immune Infiltration in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

m6A RNA Methylation Regulator-Based Signature for Prognostic Prediction and its Potential Immunological Role in Uterine Corpus Endometrial CarcinomaSemantic proximity Read ↗

N6-methylandenosine-related lncRNAs have the prognostic predictive ability for patients with Endometrial CancerSemantic proximity Read ↗

Brief analysis on the role of RNA-binding proteins in prognosis of endometrial cancer based on TCGASemantic proximity Read ↗

Exploring Prognosis-Associated Biomarkers of Estrogen-Independent Uterine Corpus Endometrial Carcinoma by Bioinformatics AnalysisSemantic proximity Read ↗

Comprehensive Analysis of the Expression of IGFBPs and its Correlation with Prognosis and Immune in Endometrial CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.